MADRIGAL Pharmaceuticals, Inc. (NASDAQ:MDGL) has reported a significant stock sale by President and CEO William John Sibold.
Following this transaction, Sibold's remaining direct ownership in MADRIGAL Pharmaceuticals stands at 55,887 shares.
In other recent news, Madrigal Pharmaceuticals (NASDAQ: ) has seen significant developments.
Other analyst firms have also weighed in on Madrigal Pharmaceuticals' prospects.
InvestingPro InsightsAmidst the recent news of MADRIGAL Pharmaceuticals, Inc.'s (NASDAQ:MDGL) CEO stock sale, investors are keenly watching the company's financial health and market performance.

Madrigal Pharmaceuticals CEO sells over $1.5m in stock By Investing.com